PRL and type 2 diabetes mellitus: In this paper, we outline evidence to support this theory, as well as highlight genetic research needs to study the dopamine and prolactin (PRL) pathway to investigate possible underlying etiopathogenesis linking psychiatric and metabolic impairment, more specifically the comorbidity of SCZ and T2D.